The European Commission has launched a new Horizon Prize: "Seamless authentication for all". EUR 4 million is available for inventing secure, privacy-friendly and affordable authentication methods for smart objects available to everyone.
Every cancer follows its own complex path. An EU-funded project is developing experimental tools and a computer model to generate and test ideas on the combined impact of the body's cell and chemical processes on cancer progress. The findings should one day help researchers and SMEs find better-targeted drugs faster.
Technology relies on new ideas. And in recent decades, there has been an explosion of new ideas about materials just a fraction of the size of a human hair. Nanomaterials - materials on the scale of nanometres - promise to improve and even revolutionise products from electricity cables to personal electronics to solar panels.
PANA has set out to develop an innovative method to diagnose Alzheimer's in its early stages, up to five years before the occurrence of clinical symptoms. This could increase the duration and quality of patients' lives considerably.
Conventional industrial chemical production requires harsh conditions and environmentally unfriendly processes to transform raw materials like crude oil into useful chemicals and plastics. But imagine if nature's own chemical cell factories could turn cheap starting materials such as organic waste leftover from farming or food processing into recyclable components for the chemical industry.
What’s your action plan? If you are planning to run the marathon or just go for a walk, chances are that your approach is completely different.
We want to give you some ideas on how to increase your outreach and learn from successful EU-funded projects.
Drugs derived from biological sources play a major role in modern healthcare, but producing them cost-effectively to keep up with rising demand is a major challenge for the pharmaceutical industry. EU-funded researchers are developing more efficient biopharmaceutical manufacturing processes that should expand patients' access to these highly effective therapies.